| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SCHRES.2005.10.011 |
| P698 | PubMed publication ID | 16309894 |
| P2093 | author name string | Qi Xu | |
| Yan Shen | |||
| Xiang Yang Zhang | |||
| Yun Long Tan | |||
| Dong Feng Zhou | |||
| Gui Ying Wu | |||
| Lian Yuan Cao | |||
| P433 | issue | 2-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 291-300 | |
| P577 | publication date | 2005-11-23 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics | |
| P478 | volume | 81 |
| Q92613362 | A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia |
| Q39633244 | A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC. |
| Q34507173 | A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics |
| Q33350202 | Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q64119019 | Association Between Medication Adherence and Oxidative Stress in Patients With First-Episode Mania |
| Q42517435 | Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia |
| Q51328235 | Associations of oxidative stress status parameters with traditional cardiovascular disease risk factors in patients with schizophrenia. |
| Q42072258 | Characterization of two oxidatively modified phospholipids in mixed monolayers with DPPC. |
| Q37699340 | Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls |
| Q48653999 | Combination of omega-3 Fatty acids, lithium, and aripiprazole reduces oxidative stress in brain of mice with mania |
| Q37139004 | Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia |
| Q38820530 | DNA Damage in Major Psychiatric Diseases |
| Q33979025 | Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients |
| Q51604488 | Decreased level of serum autoantibody against LG72 is a biosignature of amyotrophic lateral sclerosis. |
| Q91529355 | Development of a novel method for the purification of C-phycocyanin pigment from a local cyanobacterial strain Limnothrix sp. NS01 and evaluation of its anticancer properties |
| Q50736892 | Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study). |
| Q27012948 | Effect of atypical antipsychotics on fetal growth: is the placenta involved? |
| Q52672209 | Effect of in utero exposure to the atypical anti-psychotic risperidone on histopathological features of the rat placenta. |
| Q36175947 | Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. |
| Q58726394 | Effects of Stocking Density on Milk Fatty Acids Composition and Oxidative Stability of Mid- and Late-Lactating Dairy Cows |
| Q39374432 | Effects of antipsychotic drug administration on antioxidative defense enzymes in male rat kidney |
| Q48194385 | Effects of feeding a Moringa oleifera rachis and twig preparation to dairy cows on their milk production and fatty acid composition, and plasma antioxidants |
| Q50507983 | Epicatechin inhibits human plasma lipid peroxidation caused by haloperidol in vitro. |
| Q37351067 | Evaluation of antioxidant deficit in schizophrenia |
| Q39688798 | Fish oil and antipsychotic drug risperidone modulate oxidative stress in PC12 cell membranes through regulation of cytosolic calcium ion release and antioxidant system |
| Q90614827 | High-protein diet and omega-3 fatty acids improve redox status in olanzapine-treated rats |
| Q46858770 | Identification of the mitochondrial MSRB2 as a binding partner of LG72. |
| Q35166850 | Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study |
| Q34048645 | Impaired metabolic reactivity to oxidative stress in early psychosis patients |
| Q46117836 | Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro. |
| Q43233859 | Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects |
| Q44170605 | Letter to the Editor: haloperidol but not dopamine rapidly induces neuronal death: comments on 'A systematic review of the effects of antipsychotic drugs on brain volume'. |
| Q36580009 | Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls |
| Q38215504 | Lipid peroxidation in psychiatric illness: overview of clinical evidence |
| Q33601360 | Meta-analysis of oxidative stress in schizophrenia |
| Q50602362 | Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia. |
| Q36923043 | Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia |
| Q30504497 | N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice |
| Q41449646 | Neuroprotection in Schizophrenia and Its Therapeutic Implications |
| Q48307819 | Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia |
| Q59802420 | Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients |
| Q34786239 | Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics. |
| Q28265319 | Oxidative stress in psychiatric disorders: evidence base and therapeutic implications |
| Q34494844 | Oxidative stress in schizophrenia: An integrated approach |
| Q89978591 | Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia |
| Q38792346 | Possible biomarkers modulating haloperidol efficacy and/or tolerability |
| Q42745478 | Quetiapine, olanzapine and haloperidol affect human plasma lipid peroxidation in vitro |
| Q33820188 | Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. |
| Q41687474 | Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry |
| Q33506208 | Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia |
| Q35591134 | Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. |
| Q57290356 | Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia |
| Q39472796 | Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress |
| Q37890428 | The SODyssey: superoxide dismutases from biochemistry, through proteomics, to oxidative stress, aging and nutraceuticals |
| Q37516036 | The effect of agoraphobia on oxidative stress in panic disorder |
| Q45896435 | The effects of ziprasidone, clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison |
| Q89879989 | Use of Nitric Oxide and Hydrogen Peroxide for Better Yield of Wheat (Triticum aestivum L.) under Water Deficit Conditions: Growth, Osmoregulation, and Antioxidative Defense Mechanism |
| Q92156253 | Weaning Performance of Beef Cattle Calves Based on Concentrate Intake |
| Q43692301 | Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research |
| Q80213035 | [The influence of diet on mental health] |
Search more.